Free tool
FAERS Monitor: Aimovig
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 761077 or its brand name (Aimovig, Erenumab-Aooe). Reports on generic versions are filed under their own applications.
Reports
55,567
Serious
12,192
22% of reports
Hospitalization
4,696
Death reported
3,183
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- device difficult to use10,278
- accidental exposure to product10,273
- wrong technique in product usage process9,519
- drug dose omission by device6,743
- migraine5,427
- drug ineffective4,511
- headache3,684
- constipation3,196
- product storage error2,980
- injection site pain2,934
- off label use2,925
- nausea2,559
- fatigue2,422
- alopecia2,331
- pain2,098
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 10 |
| 2018 | 7,441 |
| 2019 | 11,258 |
| 2020 | 8,628 |
| 2021 | 6,012 |
| 2022 | 5,931 |
| 2023 | 5,750 |
| 2024 | 5,180 |
| 2025 | 3,093 |
| 2026 | 2,252 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,998,592 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| device difficult to useSignal | 10,278 | 69.4 | 68.1 | 587,059 |
| accidental exposure to productSignal | 10,273 | 41.8 | 41.0 | 370,101 |
| drug dose omission by deviceSignal | 6,743 | 35.6 | 34.7 | 207,792 |
| migraineSignal | 5,427 | 22.8 | 22.2 | 106,925 |
| wrong technique in product usage processSignal | 9,519 | 18.6 | 18.3 | 152,606 |
| product storage errorSignal | 2,980 | 13.3 | 12.8 | 32,880 |
| constipationSignal | 3,196 | 5.6 | 5.4 | 12,064 |
| alopeciaSignal | 2,331 | 4.5 | 4.4 | 6,403 |
| injection site painSignal | 2,934 | 3.6 | 3.5 | 5,660 |
| headacheSignal | 3,684 | 2.2 | 2.2 | 2,564 |
| drug ineffective | 4,511 | 1.3 | 1.3 | 325 |
| pain | 2,098 | 1.3 | 1.2 | 143 |
| off label use | 2,925 | 1.3 | 1.2 | 169 |
| nausea | 2,559 | 1.2 | 1.2 | 109 |
| fatigue | 2,422 | 1.2 | 1.1 | 67 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.